BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15340889)

  • 1. [Performance of carriers and non-carriers of the E280A mutation for familial Alzheimer's disease in a naming test].
    Tirado V; Muñoz C; Aguirre C; Pineda DA; Lopera F
    Rev Neurol; 2004 Aug 16-31; 39(4):322-6. PubMed ID: 15340889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of intrusive errors in a memory test as possible pre-clinical marker of familial Alzheimer disease, in E280A presenilin-1 mutation carrier].
    Tirado V; Motta M; Aguirre-Acevedo DC; Pineda DA; Lopera F
    Rev Neurol; 2008 Sep 16-30; 47(6):290-4. PubMed ID: 18803154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
    Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM; O'Neill J; Geschwind D; Medina L; Apostolova LG; Rodriguez Y; Schaffer B; Varpetian A; Tseng B; Ortiz F; Fitten J; Cummings JL; Bartzokis G
    Brain; 2007 Jul; 130(Pt 7):1767-76. PubMed ID: 17522104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Image characterization of Alzheimer's disease associated with the E280A-PS1 mutation. Case-control study: MRI findings].
    Lopera F; Tobón N; Arcos-Burgos M; Vargas S; Gutiérrez JE; Rosselli M; Ardila A
    Rev Neurol; 1999 Jul 1-15; 29(1):6-12. PubMed ID: 10528301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological profile of a large kindred with familial Alzheimer's disease caused by the E280A single presenilin-1 mutation.
    Ardila A; Lopera F; Rosselli M; Moreno S; Madrigal L; Arango-Lasprilla JC; Arcos M; Murcia C; Arango-Viana JC; Ossa J; Goate A; Kosik KS
    Arch Clin Neuropsychol; 2000 Aug; 15(6):515-28. PubMed ID: 14590205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
    Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
    Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.
    Velez-Pardo C; Arellano JI; Cardona-Gomez P; Jimenez Del Rio M; Lopera F; De Felipe J
    Epilepsia; 2004 Jul; 45(7):751-6. PubMed ID: 15230697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of antibodies to beta-amyloid in carriers of E280A mutation in the presenilin-1 gene].
    Toro F; Lopera F; Ossa J; Madrigal L; Mira A; Díaz A; Parra S
    Rev Neurol; 1999 Dec 16-31; 29(12):1104-7. PubMed ID: 10652730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive changes in the preclinical phase of familial Alzheimer's disease.
    Arango-Lasprilla JC; Cuetos F; Valencia C; Uribe C; Lopera F
    J Clin Exp Neuropsychol; 2007 Nov; 29(8):892-900. PubMed ID: 17852592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.
    Mondadori CR; Buchmann A; Mustovic H; Schmidt CF; Boesiger P; Nitsch RM; Hock C; Streffer J; Henke K
    Brain; 2006 Nov; 129(Pt 11):2908-22. PubMed ID: 17012294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption?
    Balthazar ML; Cendes F; Damasceno BP
    Neuropsychology; 2008 Nov; 22(6):703-9. PubMed ID: 18999343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linguistic changes in verbal expression: a preclinical marker of Alzheimer's disease.
    Cuetos F; Arango-Lasprilla JC; Uribe C; Valencia C; Lopera F
    J Int Neuropsychol Soc; 2007 May; 13(3):433-9. PubMed ID: 17445292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
    Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
    Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual task abilities as a possible preclinical marker of Alzheimer's disease in carriers of the E280A presenilin-1 mutation.
    MacPherson SE; Parra MA; Moreno S; Lopera F; Della Sala S
    J Int Neuropsychol Soc; 2012 Mar; 18(2):234-41. PubMed ID: 22133015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
    Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
    J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Language and cognitive impairment: a semiological study into visual naming].
    Fernández-Turrado T; Tejero-Juste C; Santos-Lasaosa S; Pérez-Lázaro C; Piñol-Ripoll G; Mostacero-Miguel E; Pascual-Millán LF
    Rev Neurol; 2006 May 16-31; 42(10):578-83. PubMed ID: 16703524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.